First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein.
It has been postulated that lipids incorporated in atherosclerotic plaques are derived from the uptake of oxidized low density lipoprotein (LDL) by a macrophage-bound receptor. In vitro studies of LDL oxidation have established that reactive lipids are formed and that the exposure of native LDL to these products leads to modified protein with physical properties similar to oxidized LDL. Here we describe the application of highly specific tandem mass spectrometric techniques to the first characterization of lipid-modified LDL by demonstrating the addition of 4-hydroxy-2-nonenal to histidine residues of apolipoprotein B-100, following oxidation of LDL. The modified residues have been assigned to specific locations that have been previously shown to reside on the surface of the LDL particle.
Michael Barber Centre for Mass Spectrometry, University of Manchester Institute of Science and Technology (UMIST), Manchester M60 1QD, United Kingdom.
M S
MS
Bolgar
C Y
CY
Yang
S J
SJ
Gaskell
D053299:Apolipoprotein B-100; D001055:Apolipoproteins B / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D008401:Gas Chromatography-Mass Spectrometry; D006639:Histidine; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*
D053299:Apolipoprotein B-100; D001055:Apolipoproteins B; D008077:Lipoproteins, LDL; D006639:Histidine